- About Us
Director, Global Market Oncology
Top Global Pharmaceutical Company
A top global pharmaceutical company sought to gain a more well-rounded understanding of the non-small cell lung cancer (NSCLC) market landscape to determine where and how to fill gaps.
Buzzback’s blended quali-quant approach integrated projective techniques, like Blobs, relationship circles and engines & anchors to reveal deeper understanding around late stage cancer patients & caregivers’ attitudes, experiences and feelings when diagnosed compared to current experiences.
With a comprehensive view of the physical, social, and psychological impacts NSCLC has on the lives of both patients and caregivers, this study provided actionable insights on how to best meet the needs of both groups. The findings were also presented at the 2019 International Society for Quality of Life (ISOQOL) conference..